We are live on ! Find out more
LABP

Landos Biopharma, Inc. Common Stock

Delisted

LABP was delisted on the 23rd of May, 2024.

Name Holding Trade Value Shares
Change
Change in
Stake
PA
1
Perceptive Advisors
New York
$7.43M
Macquarie Group
2
Macquarie Group
Australia
$74K
Renaissance Technologies
3
Renaissance Technologies
New York
$63K -$51K -13,330 -52%
Vanguard Group
4
Vanguard Group
Pennsylvania
$51.6K -$24.3K -6,352 -38%
BCM
5
Bridgeway Capital Management
Texas
$49.5K -$19.1K -5,000 -34%
SGCA
6
Steel Grove Capital Advisors
Tennessee
$47.3K +$3.83K +1,000 +12%
Geode Capital Management
7
Geode Capital Management
Massachusetts
$46K +$5.62K +1,469 +19%
HF
8
HRT Financial
New York
$26K +$20.1K +5,256 New
Deutsche Bank
9
Deutsche Bank
Germany
$20.9K
State Street
10
State Street
Massachusetts
$12.6K
BlackRock
11
BlackRock
New York
$12.2K -$104K -27,251 -92%
Susquehanna International Group
12
Susquehanna International Group
Pennsylvania
$10.5K +$8.06K +2,106 New
TRCT
13
Tower Research Capital (TRC)
New York
$9K +$2.96K +772 +77%
Jane Street
14
Jane Street
New York
$7.41K +$5.68K +1,483 New
Northern Trust
15
Northern Trust
Illinois
$6.11K
Fidelity Investments
16
Fidelity Investments
Massachusetts
$1K
Morgan Stanley
17
Morgan Stanley
New York
$384 -$3.02K -788 -91%
Citigroup
18
Citigroup
New York
$260 +$8 +2 +4%
UBS Group
19
UBS Group
Switzerland
$188 +$145 +38 New
Wells Fargo
20
Wells Fargo
California
$54 +$4 +1 +10%
RI
21
RTW Investments
New York
-$2.58M -397,572 Closed
OMC
22
OUP Management Company
Pennsylvania
-$804K -123,767 Closed
AI
23
ArchPoint Investors
Florida
-$83K -12,726 Closed
Two Sigma Advisers
24
Two Sigma Advisers
New York
-$13K -1,980 Closed
Two Sigma Investments
25
Two Sigma Investments
New York
-$13K -1,942 Closed